Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

[Obesity as a Clinical Disease: It's Time to Redefine It in Chile].

Revista medica de Chile·2026
Same journal

[Structured Exercise After Chemotherapy: New Evidence to Improve Survival in Colon Cancer].

Revista medica de Chile·2026
Same journal

[The Legacy of Dr. Lucio Córdova Labarca: The First School of Social Work in Southern Chile, Temuco, 1942].

Revista medica de Chile·2026
Same journal

[From the Laboratory to the Clinic: Biomedical Potential of Pathogen-Mimicking Polymers].

Revista medica de Chile·2026
Same journal

[Focal Neuropathies in SARS-CoV-2 Patients: Insights from a Single Center Experience].

Revista medica de Chile·2026
Same journal

[Social Cognition and Theory of Mind as a Differential Marker Between Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia].

Revista medica de Chile·2026

Related Experiment Video

Updated: Jun 8, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Interleukin (IL)-35 is raising our expectations.

Zhao Ning-Wei1

  • 1School of Biotechnology, Albanova University Center, Royal Institute of Technology (KTH), Roslagstullsbacken 21 SE-10691 Stockholm, Sweden. znw_sun@hotmail.com

Revista Medica De Chile
|October 6, 2010
PubMed
Summary

Interleukin-35 (IL-35) is a novel cytokine that regulates immune responses and alleviates inflammation. This research explores its potential therapeutic applications for autoimmune and inflammatory diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cytokine Research

Background:

  • Interleukin-35 (IL-35) is a recently identified member of the IL-12 cytokine family.
  • Its role in immune regulation and inflammatory processes is an area of active investigation.

Purpose of the Study:

  • To elucidate the function of IL-35 in immunity against parasitic and bacterial infections.
  • To discuss the anti-inflammatory properties of IL-35 and its role in autoimmunity.
  • To highlight key findings on this novel cytokine and its clinical relevance.

Main Methods:

  • Analysis of genetically deficient mouse models to understand IL-35 biology.
  • Focus on IL-35's relationship with other IL-12 family members.
  • Discussion of potential clinical applications based on research findings.

More Related Videos

Intravital Imaging of Neutrophil Priming Using IL-1β Promoter-driven DsRed Reporter Mice
09:34

Intravital Imaging of Neutrophil Priming Using IL-1β Promoter-driven DsRed Reporter Mice

Published on: June 22, 2016

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 1, 2011

Related Experiment Videos

Last Updated: Jun 8, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Intravital Imaging of Neutrophil Priming Using IL-1β Promoter-driven DsRed Reporter Mice
09:34

Intravital Imaging of Neutrophil Priming Using IL-1β Promoter-driven DsRed Reporter Mice

Published on: June 22, 2016

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 1, 2011

Main Results:

  • IL-35 is crucial for CD4+CD25+ Treg cell-mediated immune regulation and alleviation of inflammatory responses.
  • IL-35 administration suppressed autoimmune/allergic diseases in animal models, indicating therapeutic potential.
  • Unanswered questions remain regarding the IL-35 receptor, signaling pathways, and species-specific expression.

Conclusions:

  • Growing understanding of IL-35 offers new therapeutic strategies for intractable immune diseases like Lupus Erythematosus.
  • Further research into IL-35 mechanisms and receptor interactions is warranted for clinical translation.